---
$id: https://graph.org.ai/products/commodity/51142543
$type: Product
source: UNSPSC
code: "51142543"
title: "Apomorphine hydrochloride"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Apomorphine hydrochloride

**UNSPSC Code**: 51142543
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula 2C17H17NO2.2ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F39049Y068, chemically known as 6a.beta.-noraporphine-10,11-diol, 6-methyl-, hydrochloride but more generally known as apomorphine hydrochloride, which bears US NIH Compound Identifier 2215. European Medicines Agency schedules Apomorphine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12924MIG. Most nations, for tariff and trade purposes, schedule apomorphine hydrochloride under HS 29391900. As of Q4 2014, APOMORPHINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Apomorphine hydrochloride bears US NLM identifiers UMLS ID C0237406 and NCI Concept Code C47400. SMILES: CN1CCC2CCCC-3C2[C@H]1CC4C3C(C(CC4)O)O.CN1CCC2CCCC-3C2[C@H]1CC4C3C(C(CC4)O)O.O.CL.CL.

